US2011172306A1PendingUtilityA1

Creatine ester pronutrient compounds and formulations

49
Individually held — no corporate assignee on recordPriority: Sep 14, 2000Filed: Mar 23, 2011Published: Jul 14, 2011
Est. expirySep 14, 2020(expired)· nominal 20-yr term from priority
Inventors:Jonathan L. VennerstromDonald W. Miller
A61P 9/00A61P 25/00A61P 25/16A61P 3/02A23V 2002/00A61K 31/22A61K 31/7004A61P 21/00A23K 20/142A23L 33/10A61K 31/66A61K 31/221A61K 31/198
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention describes a method for providing creatine to an animal, which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.

Claims

exact text as granted — not AI-modified
1 . A method for providing creatine to an animal, comprising orally receiving a food supplement consisting essentially of creatine ethyl ester and/or a salt of creatine ethyl ester by the animal in a form suitable for being modified by the animal into creatine. 
     
     
         2 . The method according to  claim 1 , wherein said animal is a human. 
     
     
         3 . The method according to  claim 1 , wherein said animal is livestock. 
     
     
         4 . The method according to  claim 1 , wherein the food supplement is in solid form. 
     
     
         5 . The method according to  claim 4 , wherein said solid form further comprises at least one of dextrose and phosphate. 
     
     
         6 . The method according to  claim 4 , wherein said solid form is configured as at least one of a tablet and a capsule. 
     
     
         7 . The method according to  claim 1 , wherein the food supplement is in a form suitable for liquid delivery. 
     
     
         8 . The method according to  claim 7 , wherein the food supplement is in the form of an aqueous solution or emulsion. 
     
     
         9 . The method according to  claim 1 , comprising orally receiving a food supplement consisting essentially of creatine ethyl ester by a human. 
     
     
         10 . The method according to  claim 1 , comprising orally receiving a food supplement consisting essentially of creatine ethyl ester salt by a human. 
     
     
         11 . The method according to  claim 10 , comprising orally receiving a food supplement consisting essentially of creatine ethyl ester hydrochloride by a human. 
     
     
         12 . A food supplement, wherein said food supplement is suitable for administration to an animal and consists essentially of creatine ethyl ester and/or a salt of creatine ethyl ester. 
     
     
         13 . The food supplement as claimed in  claim 12 , in a form suitable for administration to a human. 
     
     
         14 . The food supplement as claimed in  claim 12 , wherein said supplement is in the form of a tablet or capsule. 
     
     
         15 . The food supplement of  claim 14 , wherein said food supplement further comprises at least one of dextrose and phosphate. 
     
     
         16 . The food supplement of  claim 13 , consisting essentially of creatine ethyl ester. 
     
     
         17 . The food supplement of  claim 13 , consisting essentially of creatine ethyl ester salt. 
     
     
         18 . The food supplement of  claim 13 , consisting essentially of creatine ethyl ester hydrochloride. 
     
     
         19 .- 34 . (canceled) 
     
     
         35 . A food supplement, wherein said food supplemental is suitable for administration to an animal, said food supplement comprising creatine ethyl ester and/or a salt of creatine ethyl ester, said creatine ethyl ester and/or salt of creatine ethyl ester being the sole agent in said food supplement which is effective to transport creatine into muscle cells of said animal in increased amounts relative to creatine monohydrate alone. 
     
     
         36 . The food supplement of  claim 35 , in a form suitable for administration to a human. 
     
     
         37 . The food supplement of  claim 35 , wherein said food supplement is in the form of a tablet or capsule. 
     
     
         38 . The food supplement of  claim 35 , wherein said food supplement further comprises at least one of dextrose and phosphate. 
     
     
         39 . The food supplement of  claim 36 , wherein said sole component is creatine ethyl ester. 
     
     
         40 . The food supplement of  claim 36 , wherein said sole component is a creatine ethyl ester salt. 
     
     
         41 . The food supplement of  claim 36 , wherein said sole component is creatine ethyl ester hydrochloride. 
     
     
         42 . A method for treating or preventing a disease state which is responsive to creatine supplementation in a patient in need thereof by administering to said patient a therapeutically or prophylactically effective amount of a supplement consisting essentially of creatine ethyl ester and/or a salt of creatine ethyl ester in a form suitable for being modified by said patient into creatine. 
     
     
         43 . The method of  claim 42 , wherein said disease state is selected from the group consisting of Parkinson's disease, Huntington's disease, mitochondrial pathologies, stroke, muscular disease, heart disease and muscle fatigue secondary to aging. 
     
     
         44 . The method of  claim 42 , wherein said creatine ethyl ester and/or salt of creatine ethyl ester is orally administered to said patient.

Join the waitlist — get patent alerts

Track US2011172306A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.